Amgen raises 2026 outlook as quarterly sales grow 8%

Amgen’s third-quarter sales rose 8% to $10.4bn and adjusted earnings increased 14% to $6.45 a share. It raised its 2026 revenue outlook to $38.9bn to $39.7bn.